MiMedx Group Inc Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 361M | Sales 2025 * | 406M | Capitalization | 1.06B |
---|---|---|---|---|---|
Net income 2024 * | 45M | Net income 2025 * | 55M | EV / Sales 2024 * | 2.92 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.6 x |
P/E ratio 2024 * |
22.9
x | P/E ratio 2025 * |
17.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.68% |
Latest transcript on MiMedx Group Inc
Managers | Title | Age | Since |
---|---|---|---|
Joe Capper
CEO | Chief Executive Officer | 61 | 23-01-26 |
Douglas Rice
DFI | Director of Finance/CFO | 58 | 23-07-04 |
John R. Harper
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Hawkins
BRD | Director/Board Member | 70 | 20-07-01 |
K. Newton
BRD | Director/Board Member | 61 | 19-06-18 |
M. Wilsey
CHM | Chairman | 71 | 19-06-18 |
1st Jan change | Capi. | |
---|---|---|
-22.96% | 122M | |
-22.04% | 58.45M | |
+0.14% | 57.71M | |
-4.19% | 50.39M |